Neil H Riordan

Summary

Publications

  1. pmc Allogeneic endometrial regenerative cells: an "Off the shelf solution" for critical limb ischemia?
    Michael P Murphy
    Division of Vascular Surgery, Indiana University School of Medicine, Indiana, USA
    J Transl Med 6:45. 2008
  2. pmc Safety evaluation of allogeneic umbilical cord blood mononuclear cell therapy for degenerative conditions
    Wan Zhang Yang
    Nanshan Affiliated Hospital of Guangdong Medical College, Shenzhen, China
    J Transl Med 8:75. 2010
  3. pmc Stem cell therapy for autism
    Thomas E Ichim
    Medistem Laboratories Inc, Tempe, Arizona, USA
    J Transl Med 5:30. 2007
  4. pmc Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis
    Neil H Riordan
    Medistem Inc, San Diego, CA, USA
    J Transl Med 7:29. 2009
  5. doi request reprint Autologous stromal vascular fraction cells: a tool for facilitating tolerance in rheumatic disease
    Thomas E Ichim
    Medistem Inc, San Diego, CA, USA
    Cell Immunol 264:7-17. 2010
  6. pmc Feasibility of combination allogeneic stem cell therapy for spinal cord injury: a case report
    Thomas E Ichim
    Medistem Inc, San Diego, USA
    Int Arch Med 3:30. 2010
  7. ncbi request reprint Tumor vaccines in 2010: need for integration
    David Koos
    Entest BioMedical, San Diego, CA, USA
    Cell Immunol 263:138-47. 2010
  8. pmc Combination stem cell therapy for heart failure
    Thomas E Ichim
    Medistem Inc, San Diego, USA
    Int Arch Med 3:5. 2010
  9. doi request reprint Mesenchymal stem cells as anti-inflammatories: implications for treatment of Duchenne muscular dystrophy
    Thomas E Ichim
    Medistem Inc, San Diego, CA 92122, USA
    Cell Immunol 260:75-82. 2010
  10. pmc Autologous stromal vascular fraction therapy for rheumatoid arthritis: rationale and clinical safety
    Jorge Paz Rodriguez
    Institute for Molecular Medicine, Huntington Beach, CA, USA
    Int Arch Med 5:5. 2012

Collaborators

Detail Information

Publications14

  1. pmc Allogeneic endometrial regenerative cells: an "Off the shelf solution" for critical limb ischemia?
    Michael P Murphy
    Division of Vascular Surgery, Indiana University School of Medicine, Indiana, USA
    J Transl Med 6:45. 2008
    ....
  2. pmc Safety evaluation of allogeneic umbilical cord blood mononuclear cell therapy for degenerative conditions
    Wan Zhang Yang
    Nanshan Affiliated Hospital of Guangdong Medical College, Shenzhen, China
    J Transl Med 8:75. 2010
    ....
  3. pmc Stem cell therapy for autism
    Thomas E Ichim
    Medistem Laboratories Inc, Tempe, Arizona, USA
    J Transl Med 5:30. 2007
    ..Additionally, anecdotal clinical cases have reported responses in autistic children receiving cord blood CD34+ cells. We propose the combined use of MSC and cord blood CD34+cells may be useful in the treatment of autism...
  4. pmc Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis
    Neil H Riordan
    Medistem Inc, San Diego, CA, USA
    J Transl Med 7:29. 2009
    ..Based on this rationale and initial experiences, we propose controlled trials of autologous SVF in various inflammatory conditions...
  5. doi request reprint Autologous stromal vascular fraction cells: a tool for facilitating tolerance in rheumatic disease
    Thomas E Ichim
    Medistem Inc, San Diego, CA, USA
    Cell Immunol 264:7-17. 2010
    ..We discuss the application of this autologous cell source in the context of rheumatoid arthritis, concluding with some practical examples of its applications...
  6. pmc Feasibility of combination allogeneic stem cell therapy for spinal cord injury: a case report
    Thomas E Ichim
    Medistem Inc, San Diego, USA
    Int Arch Med 3:30. 2010
    ..Recovery of muscle, bowel and sexual function was noted, along with a decrease in ASIA score to "D". This case supports further investigation into allogeneic-based stem cell therapies for SCI...
  7. ncbi request reprint Tumor vaccines in 2010: need for integration
    David Koos
    Entest BioMedical, San Diego, CA, USA
    Cell Immunol 263:138-47. 2010
    ..In this review we describe major advances in our understanding of tumor escape from immunological pressure and provide some possible therapeutic scenarios for enhancement of efficacy in future cancer vaccine trials...
  8. pmc Combination stem cell therapy for heart failure
    Thomas E Ichim
    Medistem Inc, San Diego, USA
    Int Arch Med 3:5. 2010
    ..We conclude by describing a case report of a heart failure patient treated with a combination stem cell protocol in an attempt to augment beneficial aspects of cord blood CD34 cells and mesenchymal-like stem cells...
  9. doi request reprint Mesenchymal stem cells as anti-inflammatories: implications for treatment of Duchenne muscular dystrophy
    Thomas E Ichim
    Medistem Inc, San Diego, CA 92122, USA
    Cell Immunol 260:75-82. 2010
    ..We conclude by describing one practical scenario of stem cell therapy for DMD...
  10. pmc Autologous stromal vascular fraction therapy for rheumatoid arthritis: rationale and clinical safety
    Jorge Paz Rodriguez
    Institute for Molecular Medicine, Huntington Beach, CA, USA
    Int Arch Med 5:5. 2012
    ..Here we describe the rationale and preclinical data supporting the use of autologous SVF in treatment of RA, as well as provide 1, 3, 6, and 13 month safety outcomes in 13 RA patients treated with this approach...
  11. pmc Feasibility investigation of allogeneic endometrial regenerative cells
    Zhaohui Zhong
    Medistem Inc, San Diego, USA
    J Transl Med 7:15. 2009
    ..These preliminary data suggest feasibility of clinical ERC administration and support further studies with this novel stem cell type...
  12. pmc Intravenous ascorbic acid as an adjuvant to interleukin-2 immunotherapy
    Samuel C Wagner
    Batu Biologics, San Diego, California, USA
    J Transl Med 12:127. 2014
    ..Here we present a scientific rationale to support the assessment of intravenous AA as an adjuvant to decrease IL-2 mediated toxicity and possibly increase treatment efficacy. ..
  13. pmc Immunotherapy for melanoma: current status and perspectives
    Doru T Alexandrescu
    Division of Dermatology, University of California at San Diego, San Diego, CA, USA
    J Immunother 33:570-90. 2010
    ..The need to engineer better immune interactions and to boost positive feedback loops appear crucial for the future of melanoma therapy, which ultimately resides in our understanding of the complexity of immune responses in this disease...
  14. pmc Nutraceutical augmentation of circulating endothelial progenitor cells and hematopoietic stem cells in human subjects
    Nina A Mikirova
    Medistem Inc, San Diego, California, USA
    J Transl Med 8:34. 2010
    ..These data suggest Stem-Kine supplementation may be useful as a stimulator of reparative processes associated with mobilization of hematopoietic and endothelial progenitors...